One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Inside This Issue
doi : 10.1016/S1936-8798(21)01373-X
Volume 14, Issue 16, 23 August 2021, Pages A11-A15
Spontaneous Coronary Artery Dissection: Pitfalls of Angiographic Diagnosis and an Approach to Ambiguous Cases
DavidAdlamBM, BCh, DPhilaMarysia S.TweetMDbRajivGulatiMD, PhDbDeeviaKotechaMB, BSaPraveenRaoMB, BSaAlistair J.MossMD, PhDaSharonne N.HayesMDb
doi : 10.1016/j.jcin.2021.06.027
Volume 14, Issue 16, 23 August 2021, Pages 1743-1756
Spontaneous coronary artery dissection (SCAD) is a pathophysiologically distinct cause of acute coronary syndromes (ACS). It is increasingly recognized that optimal management is different from that for atherosclerotic ACS and that a SCAD diagnosis has specific long-term prognostic and therapeutic implications. Accurate diagnosis is therefore essential to ensure the best treatment of patients. At present this relies on the recognition of typical features of SCAD identified on invasive coronary angiography. Although most SCAD can be readily distinguished angiographically from alternative causes of ACS, false positive and false negative diagnoses remain common. In particular, sometimes non-SCAD presentations, including atherothrombosis, takotsubo cardiomyopathy, coronary embolism, coronary vasospasm, contrast streaming, and myocardial infarction with nonobstructive coronary arteries, can mimic angiographic features usually associated with SCAD. The authors present the combined experience from European and US SCAD referral centers reviewing the classical angiographic appearances of SCAD, presenting potential diagnostic pitfalls and exemplars of SCAD mimickers. The authors further review the benefits and limitations of intracoronary imaging in the context of SCAD. Finally, the authors discuss the investigation of ambiguous cases and an approach to minimize misdiagnosis in difficult cases.
Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States
Sang Gune K.YooMDaMilanSethMSbMuthiahVaduganathanMD, MPHcCyrilRuwendeMD, PhDdMilindKarveMDeIbrahimShahMDfThomasHillMDgHitinder S.GurmMDbDevrajSukulMD MScbBlue Cross Blue Shield of Michigan Cardiovascular Consortium Investigators
doi : 10.1016/j.jcin.2021.06.036
Volume 14, Issue 16, 23 August 2021, Pages 1757-1767
The aim of this study was to evaluate the association between reported marijuana use and post–percutaneous coronary intervention (PCI) in-hospital outcomes.
Marijuana Use: A New Risk Factor for Periprocedural Bleeding??
Mamas A.MamasDPhilaPabloLamelasMDbc
doi : 10.1016/j.jcin.2021.07.002
Volume 14, Issue 16, 23 August 2021, Pages 1768-1770
Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary Intervention
DoosupShinMDa?NengDaiMDb?Seung HunLeeMD, PhDcKi HongChoiMDcAdrienLefieuxPhDdDavidMolonyPhDeDoyeonHwangMDfHyun KukKimMD, PhDgKi-HyunJeonMDhHyun-JongLeeMD, PhDiHo-JunJangMDiSang JinHaMD, PhDjTaek KyuParkMDcJeong HoonYangMD, PhDcYoung BinSongMD, PhDcJoo-YongHahnMD, PhDcSeung-HyukChoiMD, PhDcJoon-HyungDohMD, PhDk Joo MyungLeeMD, MPH, PhDc
doi : 10.1016/j.jcin.2021.06.013
Volume 14, Issue 16, 23 August 2021, Pages 1771-1785
The aim of this study was to evaluate prognostic implications of physiological 2-dimensional disease patterns on the basis of distribution and local severity of coronary atherosclerosis determined by quantitative flow ratio (QFR) virtual pull back.
Quantitative Flow Ratio, 2D Physiological Mapping, and the Negative Impact of Diffuse Disease on PCI Outcomes?
Morton J.KernMD
doi : 10.1016/j.jcin.2021.07.001
Volume 14, Issue 16, 23 August 2021, Pages 1786-1788
Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial
JochenW?hrleMDaBrunoSchellerMDbJuliaSeegerMDaAhmedFarahMDcMarc-AlexanderOhlowMDdNormanMangnerMDeSvenM?bius-WinklerMDfDanielWeilenmannMDgGeorgStachelMDhGregorLeibundgutMDiPeterRickenbacherMDjMarcoCattaneoPhDkNicoleGilgenMDjChristophKaiserMDjRaban V.JegerMDjBASKET-SMALL 2 Investigators
doi : 10.1016/j.jcin.2021.06.025
Volume 14, Issue 16, 23 August 2021, Pages 1789-1798
The study sought to evaluate the impact of diabetes mellitus on 3-year clinical outcome in patients undergoing drug-coated balloon (DCB) or drug-eluting stent (DES) treatment for de novo lesions.
Drug-Coated Balloon for Diabetic Patients With Small Coronary Vessels: Is It the Way to Go??
ManelSabatéMD, PhD
doi : 10.1016/j.jcin.2021.07.011
Volume 14, Issue 16, 23 August 2021, Pages 1799-1800
1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation: One-Month DAPT Trial
Sung-JinHongMDa?Jung-SunKimMDa?Soon JunHongMDbDo-SunLimMDbSeung-YulLeeMDcKyeong HoYunMDcJong-KwanParkMDdWoong CholKangMDeYong HoonKimMDfHyuck-JunYoonMDgHoyounWonMDhChung-MoNamPhDiChul-MinAhnMDaByeong-KeukKimMDaYoung-GukKoMDaDonghoonChoiMDaYangsooJangMDaMyeong-KiHongMDaOne-Month DAPT Investigators
doi : 10.1016/j.jcin.2021.06.003
Volume 14, Issue 16, 23 August 2021, Pages 1801-1811
The aim of this study was to determine whether 1 month of dual-antiplatelet therapy (DAPT) followed by aspirin monotherapy after polymer-free drug-coated stent (PF-DCS) implantation is noninferior to 6 to 12 months of DAPT after biodegradable-polymer drug-eluting stent (BP-DES) implantation.
Aspirin Monotherapy After BioFreedom Stent and 1-Month DAPT: Is Less More Even in Low-Risk Patients??
GiuseppeGargiuloMD, PhDGiovanniEspositoMD, PhD
doi : 10.1016/j.jcin.2021.07.005
Volume 14, Issue 16, 23 August 2021, Pages 1812-1814
Impact of Echocardiographic Guidance on Safety and Efficacy of Left Atrial Appendage Closure: An Observational Study
RobertoGaleaMDaLorenzR?berMD, PhDaMonikaFuerholzMDaJonas D.H?nerMDaGeorge C.M.SiontisMDaNicolasBruggerMDaArisMoschovitisMDbDikHegPhDcUrsFischerMDdBernhardMeierMDaStephanWindeckerMDaMarcoValgimigliMD, PhDae
doi : 10.1016/j.jcin.2021.05.042
Volume 14, Issue 16, 23 August 2021, Pages 1815-1826
The aim of this study was to evaluate the impact of echocardiographic guidance on the safety and efficacy of left atrial appendage closure (LAAC).
Fluoroscopic Guidance: An Echo From the Past??
Martin J.SwaansMD, PhDMarina F.M.HuijboomMDLucas V.A.BoersmaMD, PhD
doi : 10.1016/j.jcin.2021.07.003
Volume 14, Issue 16, 23 August 2021, Pages 1827-1829
The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure
Keerat RaiAhujaMDa?Robert W.ArissBSb?SalikNazirMDbRohitVyasMDbAnas M.SaadMDcMichaelMaccioccaMDaGeorge V.MoukarbelMDb
doi : 10.1016/j.jcin.2021.06.008
Volume 14, Issue 16, 23 August 2021, Pages 1830-1839
Getting (Left Atrial Appendage) Closure With Kidney Disease?
Matthew W.SherwoodMD, MHSaSean D.PokorneyMD, MBAb
doi : 10.1016/j.jcin.2021.07.009
Volume 14, Issue 16, 23 August 2021, Pages 1840-1842
Intimal Flap Sealing and Healing of Spontaneous Coronary Artery Dissection With Drug-Eluting Balloons
AntonioLandiMDaAngeloQuaglianaMDaLaura AnnaLeoMDaFrancesco FulvioFaletraMDaGiovanniPedrazziniMDabMarcoValgimigliMD, PhDac
doi : 10.1016/j.jcin.2021.06.017
Volume 14, Issue 16, 23 August 2021, Pages 1843-1845
Large LAA—Too Big for Closure?: LAA Closure With the World’s Biggest Percutaneous Closure Device
CarstenSkurkMDabMarkusReinthalerMDacMarioKasnerMDaUlfLandmesserMDabd
doi : 10.1016/j.jcin.2021.05.016
Volume 14, Issue 16, 23 August 2021, Pages 1846-1847
Billowing Motion of the Polyester Fabric Cover With WATCHMAN FLX Device: The Wind Sailing Effect
ErwanSalaunMD, PhDIria SilvaCondeMDKimO’ConnorMDJonathanBeaudoinMDFlorenceBernierGillesO’HaraMDJeanChampagneMDJean-MichelParadisMDNicolasDogninMDMaryseLemyreRNJosepRodes-CabauMDMathieuBernierMD
doi : 10.1016/j.jcin.2021.04.035
Volume 14, Issue 16, 23 August 2021, Pages e201-e204
Transcatheter Pulmonary Valve Replacement With “Kissing” Coronary Intervention for Coronary Compression in High-Risk Patient
Grant A.HendersonMDJoannaGhobrialMD, MSc
doi : 10.1016/j.jcin.2021.02.028
Volume 14, Issue 16, 23 August 2021, Pages e205-e209
Late Percutaneous Closure of the Right Sinus of Valsalva Fistula After Transcatheter Aortic Valve Replacement
FemiPhilipMDaJames M.SchipperMDaQasemNooriMDaJosephHuhMDb
doi : 10.1016/j.jcin.2021.05.022
Volume 14, Issue 16, 23 August 2021, Pages e211-e213
Successful Transcatheter Recanalization of a Chronically Occluded Left Pulmonary Artery Due to Fibrosing Mediastinitis
Michael D.SeckelerMD, MScaJ.R. Exequiel T.PinedaMD, PhDbKapilLotunMDb
doi : 10.1016/j.jcin.2021.04.004
Volume 14, Issue 16, 23 August 2021, Pages e215-e216
Coronary Occlusion During Transcatheter Aortic Valve Replacement With an Anomalous Origin of Left Coronary Artery
FumiakiYashimaMD, PhDabTakuInoharaMD, PhDbKenichiHashizumeMD, PhDcKojiUenoMD, PhDaKeiichiFukudaMD, PhDb
doi : 10.1016/j.jcin.2021.04.041
Volume 14, Issue 16, 23 August 2021, Pages e217-e218
Occluded Left Subclavian With Unusual Collateral Blood Supply From the Right Vertebral Artery
EliasHellouMDabArielRoguinMD, PhDab
doi : 10.1016/j.jcin.2021.04.051
Volume 14, Issue 16, 23 August 2021, Pages e219-e220
Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients
Richard A.ChazalMDC. MichaelValentineMD
doi : 10.1016/j.jcin.2021.06.022
Volume 14, Issue 16, 23 August 2021, Page 1848
Reply: Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients
JoergHerrmannMDWeiGuoMDXiminFanMDCharanjitRihalMDAmirLermanMD
doi : 10.1016/j.jcin.2021.07.012
Volume 14, Issue 16, 23 August 2021, Page 1849
The Obstacles in Comparing Observational Studies With Clinical Trials
Akhil S.KallurMDJorge SanzS?nchezMD, PhDHector M.Garcia-GarciaMD, PhD
doi : 10.1016/j.jcin.2021.06.023
Volume 14, Issue 16, 23 August 2021, Pages 1849-1850
NSTEMI Versus STEMI and Cardiogenic Shock: Are Multivessel Interventions Better in One and Not the Other?
Gauravpal S.GillMDArunKanmanthareddyMD, MS
doi : 10.1016/j.jcin.2021.06.038
Volume 14, Issue 16, 23 August 2021, Pages 1850-1851
Reply: Multivessel Versus Culprit-Vessel PCI in Patients With NSTEMI and Cardiogenic Shock
Mohamed A.OmerMD, MSEmmanouil S.BrilakisMD, PhDIslam Y.ElgendyMDPaul S.ChanMD, MScJohn A.SpertusMD, MPH
doi : 10.1016/j.jcin.2021.07.013
Volume 14, Issue 16, 23 August 2021, Pages 1851-1852
Intraprocedural Hybrid Cardiac Computed Tomography for Left Atrial Appendage Occlusion: A Concept and Feasibility Study
MahdiVeillet-ChowdhuryMDStewart M.BentonJr.MDC. Anwar A.ChahalMBChB, PhDJames E.HarveyMD, MScPaulTolericoMDWilliamNicholsonMDGhaith SharafDabbaghMDFrancescaPugliesePhDMohammedKhanjiMBBS, PhDSamanNazarianMD, PhDBrianSchulerMD
doi : 10.1016/j.jcin.2021.05.044
Volume 14, Issue 16, 23 August 2021, Pages 1852-1853
Immersive Virtual Reality Heart Models for Planning of Transcatheter Paravalvular Leak Closure: A Feasibility Study
Amir H.SadeghiMD, MSc†Joris F.OomsMD†WouterBakhuisMD, MScYannick J.H.J.TaverneMD, PhD, MScNicolas M.Van MieghemMD, PhD‡Ad J.J.C.BogersMD, PhD‡
doi : 10.1016/j.jcin.2021.06.018
Volume 14, Issue 16, 23 August 2021, Pages 1854-1856
